Promising Drug On The Horizon For COVID-19
A drug that's been tested against the coronaviruses that cause MERS and SARS and shown to have valuable antiviral properties appears to be potent against the COVID-19 virus as well. (Source: NPR Health and Science)
Source: NPR Health and Science - April 6, 2020 Category: Consumer Health News Authors: Joe Palca Source Type: news
Coronavirus Diagnosis Prompts Mass General Hospital Doctor To Join Experimental Drug Study
BOSTON (AP) – The new coronavirus made Dr. Jag Singh a patient at his own hospital. His alarm grew as he saw an X-ray of his pneumonia-choked lungs and colleagues asked his wishes about life support while wheeling him into Massachusetts General’s intensive care unit.
When they offered him a chance to help test remdesivir, an experimental drug that’s shown promise against some other coronaviruses, “it did not even cross my mind once to say ‘no,’” said Singh, a heart specialist.
Coronavirus patients around the world have been rushing to join remdesivir studies that opened in hospitals in the last few weeks.
Int...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 6, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Featured Health Syndicated CBSN Boston Coronavirus Mass General Hospital Source Type: news
Can You Be Re-Infected After Recovering From Coronavirus? Here ’s What We Know About COVID-19 Immunity
Troubling headlines have been cropping up across Asia: Some patients in China, Japan and South Korea who were diagnosed with COVID-19 and seemingly recovered have been readmitted to the hospital after testing positive for the virus again.
Because SARS-CoV-2, the novel coronavirus that causes COVID-19, was only discovered a few months ago, scientists are still trying to answer many big questions related to the virus and the disease it causes. Among them is whether patients can be reinfected by the virus after they seem to recover from the symptoms.
With other coronavirus strains, experts say the antibodies that patients p...
Source: TIME: Health - April 3, 2020 Category: Consumer Health News Authors: Hillary Leung Tags: Uncategorized COVID-19 Explainer overnight UnitedWeRise20Disaster Source Type: news
Confronting COVID-19: My Experience On The Front Line
I was on the front lines for AIDS, SARS, MERS, H1N1, GHB, bioterror, designer drugs, disasters, and mass shootings. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 2, 2020 Category: Pharmaceuticals Authors: Richard Klasco, Contributor Source Type: news
A Drug Developed to Fight Ebola Could Hold Hope for Coronavirus Treatment
Last year, when I visited the town of Beni, in the Democratic Republic of the Congo (DRC), people did not shake hands. Bottles of disinfectant and buckets of chlorinated water were at the entrance of every business. Misinformation spread across social networks and on news-sites, and treatment centers in the northeastern province of North Kivu were being attacked by armed militias.
At the time, Beni was one of the centers of a devastating Ebola outbreak, the second most deadly in world history. According to the World Health Organization, almost 3,500 people were sickened by the virus, and more than 2,000 died, a case fatali...
Source: TIME: Health - April 1, 2020 Category: Consumer Health News Authors: Nicolas Niarchos Tags: Uncategorized COVID-19 Source Type: news
Emerging Coronaviruses in Two Decades: SARS, MERS, COVID-19 Emerging Coronaviruses in Two Decades: SARS, MERS, COVID-19
A brief synopsis and comparisons of the three coronaviruses which have emerged since 2003: SARS-CoV, MERS-CoV, and now COVID-19.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 30, 2020 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news
How the virus that causes COVID-19 differs from other coronaviruses
Coronaviruses are a family of viruses that can cause illnesses such as the common cold, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). So what makes those coronaviruses different from SARS-CoV-2, the virus that causes COVID-19? Dr. Clayton Cowl, a pulmonologist and chair of Mayo Clinic's Division of Preventive, Occupational and Aerospace Medicine, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 29, 2020 Category: Databases & Libraries Source Type: news
Coronavirus: Doctor reveals why COVID-19 is so dangerous - it's to do with the symptoms
CORONAVIRUS will go down in history as the pandemic that interrupted the way people lived across the world. Dr Anna Hemming gives her medical expertise on the notorious virus - what makes it so different to SARS and MERS? (Source: Daily Express - Health)
Source: Daily Express - Health - March 29, 2020 Category: Consumer Health News Source Type: news
Is the U.S. ‘Flattening the Curve?’ Check Our Coronavirus Chart for Daily Updates
Every day, the number of Americans confirmed as infected by the virus that causes COVID-19 is higher than the day before. Such is the brutality of exponential growth: Not only does the raw number of COVID-19 cases grow, the rate at which it grows increases as well.
The following charts show how six nations, including the U.S., have either managed to stem the tide of the novel coronavirus, or are poised for an explosive growth in cases. TIME will update these charts daily.
As physician and global health and public policy professor Gavin Yamey wrote in TIME last week, “The United States has a narrow window of opport...
Source: TIME: Health - March 26, 2020 Category: Consumer Health News Authors: Elijah Wolfson and Chris Wilson Tags: Uncategorized COVID-19 interactive UnitedWeRise20Disaster Source Type: news
Blood Plasma Treatment for Coronavirus Set to Get Its First Trial Run in New York
The New York Blood Center (NYBC) is the first blood-gathering organization in the U.S. to collect plasma from COVID-19 patients to use as a possible treatment for the disease.
Before antibiotics rendered the practice moot, it was common to treat infectious bacterial diseases by infusing the blood of recovered patients into those struggling with infection. That approach has also been tried against viral infections like H1N1 influenza, SARS and MERS, with inconsistent success. Some patients benefited, but other did not and doctors don’t have a clear understanding of why. But during an evolving pandemic like COVID-19, p...
Source: TIME: Health - March 26, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
East Asian Lessons for Controlling Covid-19
By Nazihah Muhamad Noor and Jomo Kwame SundaramKUALA LUMPUR, Malaysia, Mar 26 2020 (IPS) By the third week of March 2020, the number of Covid-19 deaths in Italy had overtaken the number of deaths in China. Authorities all over the world are restricting the movements of their populations as part of efforts to control the spread of Covid-19.
For the time being, more and more governments are benchmarking their responses on the very worst outbreaks in Wuhan and northern Italy. But lockdowns inevitably have adverse economic impacts, especially for businesses, particularly small ones heavily reliant on continuous turnover. Are ...
Source: IPS Inter Press Service - Health - March 26, 2020 Category: International Medicine & Public Health Authors: Nazihah Muhamad Noor and Jomo Kwame Sundaram Tags: Asia-Pacific Economy & Trade Featured Global Globalisation Headlines Health Human Rights Humanitarian Emergencies TerraViva United Nations Source Type: news
Clinical Guidance and Coronavirus: Deploying a Mass Casualty Mindset to Stay Ahead of “The Curve”
Source: World Association for Disaster and Emergency Medicine (WADEM). Published: 3/24/2020.
This one-hour, 25-minute webinar provides clear and concrete clinical applications of the World Health Organization and Centers for Disease Control and Prevention COVID-19 guidelines, as well as those of various emergency management/critical care professional societies for front-line practitioners. It examines lessons learned from the Ebola, SARS, H1N1, H5N1, and MERS outbreaks; Las Vegas Shooting; and Military Mass Casualty Management.
(Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - March 24, 2020 Category: International Medicine & Public Health Source Type: news
Can Coronavirus Affect Pregnancy or Newborns? Here ’s What the Experts Say
More than 130 million women give birth around the world each year. During pregnancy, changes in the immune system make women generally more susceptible to respiratory infections. And this year, pregnant women also have to worry about COVID-19, a virus that can affect a person’s lungs and airways.
The U.K. government announced on Monday that pregnant women were at an increased risk of severe illness from coronavirus (COVID-19). Speaking at a press conference, Public Health England chief medical officer Chris Whitty said people in the “high risk” category should stay at home for 12 weeks. (That includes pe...
Source: TIME: Health - March 20, 2020 Category: Consumer Health News Authors: Madeline Roache Tags: Uncategorized COVID-19 Explainer Londontime Source Type: news
Remdesivir Works Against Coronaviruses in the Lab
The antiviral disables RNA replication machinery in MERS and SARS viruses. Can it beat back SARS-CoV-2? (Source: The Scientist)
Source: The Scientist - March 20, 2020 Category: Science Tags: News & Opinion Source Type: news
COVID-19 in Africa: Fewer Cases So Far, and More Preparation Needed
This article is republished from The Conversation under a Creative Commons license. Read the original article.
The post COVID-19 in Africa: Fewer Cases So Far, and More Preparation Needed appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - March 19, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Africa Headlines Health Coronavirus Source Type: news
